Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.02
-0.10 (-0.37%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Castle Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 116.73 | 119.71 | 98.84 | 122.95 | 329.63 | Upgrade
|
| Short-Term Investments | 182.78 | 173.42 | 144.26 | 135.68 | - | Upgrade
|
| Cash & Short-Term Investments | 299.51 | 293.13 | 243.1 | 258.63 | 329.63 | Upgrade
|
| Cash Growth | 2.17% | 20.58% | -6.00% | -21.54% | -19.57% | Upgrade
|
| Accounts Receivable | 43.38 | 51.22 | 38.3 | 23.48 | 17.28 | Upgrade
|
| Other Receivables | 1.1 | 0.6 | - | - | - | Upgrade
|
| Receivables | 44.48 | 51.82 | 38.3 | 23.48 | 17.28 | Upgrade
|
| Inventory | 10.25 | 8.14 | 7.94 | 3.98 | 2.02 | Upgrade
|
| Prepaid Expenses | 6.86 | 7.07 | 6.29 | 6.21 | 4.81 | Upgrade
|
| Total Current Assets | 361.1 | 360.15 | 295.64 | 292.29 | 353.74 | Upgrade
|
| Property, Plant & Equipment | 112.24 | 62.71 | 37.74 | 26.5 | 16.88 | Upgrade
|
| Goodwill | 10.69 | 10.69 | 10.69 | 10.69 | - | Upgrade
|
| Other Intangible Assets | 88.88 | 95.54 | 106.64 | 115.66 | 88.92 | Upgrade
|
| Other Long-Term Assets | 5.65 | 2.15 | 2.63 | 2.2 | 3.02 | Upgrade
|
| Total Assets | 578.56 | 531.24 | 453.34 | 447.33 | 462.57 | Upgrade
|
| Accounts Payable | 18.71 | 6.9 | 10.27 | 4.73 | 2.55 | Upgrade
|
| Accrued Expenses | 45.1 | 38.7 | 35.26 | 29.21 | 20.5 | Upgrade
|
| Current Portion of Long-Term Debt | 0.42 | 0.28 | - | - | - | Upgrade
|
| Current Portion of Leases | 1.43 | 1.77 | 1.21 | 1.93 | 1.28 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.4 | - | - | Upgrade
|
| Other Current Liabilities | 3.02 | 1.75 | 0.54 | 0.27 | 0.56 | Upgrade
|
| Total Current Liabilities | 68.68 | 49.39 | 47.67 | 36.13 | 24.89 | Upgrade
|
| Long-Term Debt | 9.64 | 9.75 | - | - | - | Upgrade
|
| Long-Term Leases | 25.53 | 14.66 | 14.2 | 11.62 | 7.02 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2.34 | 1.61 | 0.21 | 0.43 | 0.64 | Upgrade
|
| Other Long-Term Liabilities | 1.5 | - | - | - | 18.29 | Upgrade
|
| Total Liabilities | 107.68 | 75.4 | 62.07 | 48.18 | 50.83 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 694.86 | 655.7 | 609.48 | 560.41 | 505.48 | Upgrade
|
| Retained Earnings | -224.28 | -200.13 | -218.37 | -160.91 | -93.77 | Upgrade
|
| Comprehensive Income & Other | 0.27 | 0.23 | 0.14 | -0.38 | - | Upgrade
|
| Total Common Equity | 470.87 | 455.84 | 391.27 | 399.15 | 411.74 | Upgrade
|
| Shareholders' Equity | 470.87 | 455.84 | 391.27 | 399.15 | 411.74 | Upgrade
|
| Total Liabilities & Equity | 578.56 | 531.24 | 453.34 | 447.33 | 462.57 | Upgrade
|
| Total Debt | 37.02 | 26.45 | 15.41 | 13.55 | 8.31 | Upgrade
|
| Net Cash (Debt) | 262.49 | 266.69 | 227.69 | 245.08 | 321.33 | Upgrade
|
| Net Cash Growth | -1.57% | 17.13% | -7.09% | -23.73% | -21.60% | Upgrade
|
| Net Cash Per Share | 9.06 | 9.12 | 8.50 | 9.41 | 12.78 | Upgrade
|
| Filing Date Shares Outstanding | 29.73 | 28.51 | 27.45 | 26.58 | 25.41 | Upgrade
|
| Total Common Shares Outstanding | 29.69 | 28.48 | 27.41 | 26.55 | 25.38 | Upgrade
|
| Working Capital | 292.42 | 310.76 | 247.97 | 256.16 | 328.86 | Upgrade
|
| Book Value Per Share | 15.86 | 16.00 | 14.27 | 15.03 | 16.22 | Upgrade
|
| Tangible Book Value | 371.3 | 349.61 | 273.93 | 272.8 | 322.82 | Upgrade
|
| Tangible Book Value Per Share | 12.51 | 12.27 | 9.99 | 10.27 | 12.72 | Upgrade
|
| Land | 7.25 | 7.25 | - | - | - | Upgrade
|
| Machinery | 42.6 | 32.48 | 22.92 | 15.35 | 7.47 | Upgrade
|
| Construction In Progress | 51.06 | 9.61 | 0.64 | 1.28 | 0.03 | Upgrade
|
| Leasehold Improvements | 14.83 | 14.62 | 9.99 | 5.17 | 5.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.